Pillstats
Rx only · Tablet, Film Coated · Oral

Aamlodipine And Olmesartan Medoxomil

Brands: Amlodipine And Olmesartan Medoxomil · Amlodipine Besylate + Olmesartan Medoxomil

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)118463
US makers1 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.090$0.179$0.269$0.359Dec 2025Mar 2026Jul 2026
$0.303
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

991972963942025 Q42026 Q1
343
Rx · 2026 Q1
16K
Units dispensed
2
Quarters · since 2025 Q4

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Camber Pharmaceuticals, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.